Home
Rowe On Monday – A fruitful Femme for Murray, Monds’ time to reflect, Hutch hails new investment and a Libyan dream lives on
In this week’s Rowe On Monday, Peter Murray on owning a sudden blue hen, Linda Monds reflects on the state of the industry, Sebastian Hutch on where the new investment is coming from and Dr Ahmed’s Australian flavour to his Libyan thoroughbred renaissance.
Sign Up to our free newsletters today
Daily and feature newsletters, covering all the
latest in racing, wagering and breeding, direct to your inbox
Latest
Sleip learning curve – Racing NSW to trial AI gait technology rather than mandating use
Amid a stern backlash from trainers about the lack of consultation and the Racing NSW veterinary department’s planned implementation of the Sleip App, the regulator has revealed it will embark on a trial period following criticism from much of the training fraternity.
From The Newsdesk
Featured
Rowe On Monday – A fruitful Femme for Murray, Monds’ time to reflect, Hutch hails new investment and a Libyan dream lives on
In this week’s Rowe On Monday, Peter Murray on owning a sudden blue hen, Linda Monds reflects on the state of the industry, Sebastian Hutch on where the new investment is coming from and Dr Ahmed’s Australian flavour to his Libyan thoroughbred renaissance.
Letter To The Editor – Matt Cumani – Don’t turn the Derby into a Dodo
Trainer Matt Cumani mounts a vigorous defense of the Victoria Derby in its current form, arguing, among other things, that thoroughbred racing can not just be made to be a measure of speed.
Straight Talk – Rising costs for trainers, cuts to Tassie meetings and the future for smaller breeders and live broodmare sales
Straight Talk looks at training costs amid concerns about ATC increases, Tasmania’s reduced race meeting schedule, challenges for smaller breeders and much, much more.
Losing Sleip – Trainers call for trial of lameness app before mandatory introduction
NSW trainers have urged Racing NSW to trial the Sleip AI lameness detection app before mandating its full use across the state, citing unanswered questions over costs, compliance and how the technology’s findings will be applied.
